top of page

Syndyam 400 mg Injection

SKU Cipla Ltd
السعر الأصلي

1,333.01$

سعر البيع

1,039.75$

Syndyam 400 mg Injection is a targeted anti-cancer therapy that plays a crucial role in the treatment of various malignancies, including colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and ovarian cancer. This medication contains the active ingredient Bevacizumab, a monoclonal antibody designed to inhibit the activity of vascular endothelial growth factor (VEGF), a protein that promotes blood vessel formation in tumors. By blocking VEGF, Syndyam effectively starves cancerous cells of the oxygen and nutrients they need to grow and proliferate. When used in conjunction with other chemotherapy agents, Syndyam 400 mg enhances treatment efficacy and improves patient outcomes. It is important to note that patients may experience side effects, including high blood pressure and increased risk of bleeding, necessitating close monitoring by healthcare professionals. Prior to treatment, individuals should discuss their complete medical history and any existing health conditions with their doctor to ensure the safe use of this medication. With its targeted approach, Syndyam represents a significant advancement in cancer therapy, offering hope for better management of challenging cancers.

الكمية

Active Pharmaceutical Ingredient

Bevacizumab 400 mg

Uses

• Syndyam 400 mg injection is utilized in the treatment of colorectal cancer, which affects the colon or rectum. Patients may experience symptoms such as changes in bowel habits, abdominal pain, and fatigue. This medication works by targeting cancer cells, helping to manage the disease effectively. It is often used in various stages of treatment, depending on the patient's condition.
• In cases of non-small cell lung cancer, Syndyam 400 mg injection serves as a therapeutic option. This type of lung cancer can lead to persistent coughing, chest discomfort, and unintentional weight loss. By targeting the cancerous cells, Syndyam helps to alleviate symptoms and improve the quality of life for affected individuals. It is commonly administered as part of a comprehensive treatment plan.
• Syndyam 400 mg injection is also indicated for the treatment of glioblastoma, a serious form of brain cancer. Symptoms of glioblastoma may include headaches, seizures, and cognitive changes. The injection works to inhibit tumor growth, providing critical support in managing this aggressive cancer. It is typically used in conjunction with other therapies to enhance patient outcomes.
• Additionally, Syndyam 400 mg injection is effective in managing kidney cancer, which arises from the kidney's filtering cells. Patients may present with symptoms such as blood in the urine, back pain, and fatigue. The medication assists in controlling the progression of the disease by targeting the cancerous cells. It is an integral part of a multi-faceted approach to treatment for kidney cancer.

Benefits

Syndyam 400 mg Injection can help to slow or stop the growth of cancer cells, which may lead to a reduction in the size of tumors or the spread of cancer to other parts of the body. Syndyam 400 mg Vial may help to reduce the risk of cancer progressing, which may improve the chances of successful long-term treatment outcomes. In some studies, Syndyam 400 mg has been shown to improve survival rates in people with certain types of cancer, including colorectal, ovarian, and lung cancer.

Side Effects

Like all medications, Syndyam 400 mg Bevacizumab Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Body Weakness
• Constipation
• Loss of Appetite
• Speech Change
• Nausea
• Diarrhoea

Common Side Effects

• Allergic Reactions
• Delay in Wound Healing
• Change in Vision
• Headache
• High Blood Pressure

How To Use

Syndyam 400 mg Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Syndyam 400 mg will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this Syndyam 400 mg Vial.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Anti-cancer Injection Syndyam. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Anti-cancer Injection Syndyam and report any unusual symptoms or changes in kidney function to their physician. The dose of Syndyam 400 mg Bevacizumab Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Syndyam 400 mg Bevacizumab Injection. Syndyam 400 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Bevacizumab Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Bevacizumab Injection if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Syndyam 400 mg may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Injection Syndyam during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Syndyam 400 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Syndyam 400 mg Vial.

bottom of page